Items where Author is "Uharek, L."

Article

Neuenhahn, M. and Albrecht, J. and Odendahl, M. and Schlott, F. and Doessinger, G. and Schiemann, M. and Lakshmipathi, S. and Martin, K. and Bunjes, D. and Harsdorf, S. and Weissinger, E. M. and Menzel, H. and Verbeek, M. and Uharek, L. and Kroeger, N. and Wagner, E. and Kobbe, G. and Schroeder, T. and Schmitt, M. and Held, G. and Herr, W. and Germeroth, L. and Bonig, H. and Tonn, T. and Einsele, H. and Busch, D. H. and Grigoleit, G. U. (2017) Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT. LEUKEMIA, 31 (10). pp. 2161-2171. ISSN 0887-6924, 1476-5551

Koenigsmann, M. and Casper, J. and Kahl, C. and Basara, N. and Sayer, H. G. and Behre, G. and Theurich, S. and Christopeit, M. and Mohren, M. and Reichle, A. and Metzner, B. and Ganser, A. and Stadler, M. and Uharek, L. and Balleisen, L. and Hinke, A. and Hinke, R. and Niederwieser, D. (2014) Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial. BONE MARROW TRANSPLANTATION, 49 (3). pp. 410-415. ISSN 0268-3369, 1476-5365

Koenigsmann, M. and Kahl, C. and Freund, M. and Basara, N. and Niederwieser, D. and Sayer, H. and Theurich, S. and Christopeit, M. and Behre, G. and Mohren, M. and Franke, A. and Reichle, A. and Ganser, A. and Metzner, B. and Uharek, L. and Balleisen, L. and Hinke, A. and Hinke, R. and Casper, J. (2010) Risk-adapted high-dose therapy including autologous and allogeneic stem cell transplantation for relapsed or aggressive non-Hodgkin's lymphoma - a phase II trial by the OSHO (East German Study Group for Haematology and Oncology). BONE MARROW TRANSPLANTATION, 45. S253. ISSN 0268-3369

Schmidt-Hieber, M. and Blau, I. W. and Trenschel, R. and Andreesen, R. and Stuhler, G. and Einsele, H. and Kanz, L. and Keilholz, U. and Marinets, O. and Beelen, D. W. and Fauser, A. A. and Volin, L. and Ruutu, T. and Uharek, L. and Fietz, T. and Knauf, W. and Hopfenmueller, W. and Thiel, E. and Freund, M. and Casper, J. (2007) Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma. BONE MARROW TRANSPLANTATION, 39 (7). pp. 389-396. ISSN 0268-3369

Schmidt-Hieber, M. and Casper, J. and Trenschel, R. and Andreesen, R. and Einsele, H. and Kanz, L. and Fauser, A. and Uharek, L. and Thiel, E. and Blau, I. (2006) Reduced-intensity conditioning with treosulfan and fludarabine prior to allogeneic stem cell transplantation in multiple myeloma patients. BONE MARROW TRANSPLANTATION, 37 (Suppl1). S195-S196. ISSN 0268-3369

Wolff, Daniel and Wilhelm, S. and Hahn, J. and Gentilini, C. and Hilgendorf, I. and Steiner, B. and Kahl, C. and Junghanss, C. and Hartung, G. and Casper, J. and Uharek, L. and Holler, E. and Freund, M. (2006) Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. BONE MARROW TRANSPLANTATION, 38 (6). pp. 445-451. ISSN 0268-3369

Conference or Workshop Item

Kahl, C. and Wolff, D. and Nogai, A. and Kundt, G. and Hahn, J. and Holler, E. and Uharek, L. and Junghanss, C. and Leithaeuser, M. and Thiel, E. and Freund, M. (2009) Limited chronic GvHD significantly improves outcome after allogeneic haematopoietic stem cell transplantation in advanced haematological diseases. In: 35th Annual Meeting of the European Group for Blood and Marrow Transplantation, March 29-April 01, 2009, Göteborg, Sweden.

Other

Christopeit, M. and Tischer, J. and Schetelig, J. and Bomhaeuser, M. and Uharek, L. and Wolff, D. and Holler, E. and Pfrepper, C. and Behre, G. and Niederwieser, D. and Kroeger, N. and Kobbe, G. and Weber, T. and Mueller, L. P. and Roesler, W. and Klein, S. and Hausmann, A. and Beelen, D. W. and Bethge, W. and Schmid, C. (2016) Haploidentical second allogeneic hematopoietic stem cell transplantation for the treatment of acute leukemia relapse after first allo-HSCT: An updated retrospective registry analysis of 69 pts on behalf of the German Cooperative Transplant Group. KARGER, BASEL.

Christopeit, M. and Tischer, J. and Bornhaeuser, M. and Uharek, L. and Wolff, D. and Holler, E. and Pfrepper, C. and Behre, G. and Niederwieser, D. and Kroeger, N. and Kobbe, G. and Weber, T. and Mueller, L. P. and Roesler, W. and Klein, S. and Hausmann, A. and Beelen, D. W. and Bethge, W. and Schmid, C. (2015) Haploidentical second allogeneic hematopoietic stem cell transplantation for the treatment of acute leukemia relapse after first allo-HSCT: An updated retrospective registry analysis of 68 patients on behalf of the German Cooperative Transplant Group. NATURE PUBLISHING GROUP, LONDON.